IWR-1 10 mg | 98.46%
TargetMol
IWR-1, a Wnt pathway inhibitor, stabilizes the Axin destruction complex(EC50=0.2 uM).
More Information Supplier PageIWR-1
Search Results
IWR-1 5 mg | 98.46%
TargetMol
IWR-1, a Wnt pathway inhibitor, stabilizes the Axin destruction complex(EC50=0.2 uM).
More Information Supplier PageIWR-1
Alda-1 100 mg | 99.93%
TargetMol
Alda-1 is an ALDH2 agonist, a cell-permeable activator of both the wild-type ALDH2*1 and the Asian E487K mutant ALDH2*2 forms of mitochondrial aldehyde dehydrogenase 2 (mtALDH2).
More Information Supplier PageAlda-1
Alda-1 10 mg | 99.93%
TargetMol
Alda-1 is an ALDH2 agonist, a cell-permeable activator of both the wild-type ALDH2*1 and the Asian E487K mutant ALDH2*2 forms of mitochondrial aldehyde dehydrogenase 2 (mtALDH2).
More Information Supplier PageAlda-1
Alda-1 5 mg | 99.93%
TargetMol
Alda-1 is an ALDH2 agonist, a cell-permeable activator of both the wild-type ALDH2*1 and the Asian E487K mutant ALDH2*2 forms of mitochondrial aldehyde dehydrogenase 2 (mtALDH2).
More Information Supplier PageAlda-1
Salidroside 10 mg | 99.25%
TargetMol
Salidroside is a bioactive phenolic glycoside compound isolated from Rhodiola crenulata. It is a prolyl endopeptidase Inhibitor.
More Information Supplier PageSalidroside
Salidroside 5 mg | 99.25%
TargetMol
Salidroside is a bioactive phenolic glycoside compound isolated from Rhodiola crenulata. It is a prolyl endopeptidase Inhibitor.
More Information Supplier PageSalidroside
Caryophyllene oxide 100 mg | 99.71%
TargetMol
Caryophyllene oxide is isolated from Aegle marmelos, with anti-inflammatory activity.
More Information Supplier PageCaryophyllene oxide
Reboxetine 10 mg | Purity Not Available
TargetMol
Reboxetine is an antidepressant drug used in the treatment of clinical depression, panic disorder and ADD/ADHD. Its mesylate (i.e. methanesulfonate) salt is sold under trade names including Edronax, Norebox, Prolift, Solvex, Davedax or Vestra. Reboxetine has two chiral centers, but it only exists as two enantiomers, (R, R)-(-)- and (S, S)-(+)-reboxetine.
More Information Supplier PageReboxetine
Brivanib (alaninate) 5 mg | 99.23%
TargetMol
Brivanib Alaninate (BMS-582664) is the alaninate salt of a vascular endothelial growth factor receptor 2 (VEGFR2) inhibitor with potential antineoplastic activity. Brivanib strongly binds to and inhibits VEGFR2, a tyrosine kinase receptor expressed almost exclusively on vascular endothelial cells; inhibition of VEGFR2 may result in inhibition of tumor angiogenesis, inhibition of tumor cell growth, and […]
More Information Supplier PageBrivanib (alaninate)
